Sign in

CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company

Cullinan Therapeutics, Inc.

Sign in to watch
Ticker
CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
813879991
Phone
617-410-4650
Business address
ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
Former names
Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. EFFECT Other Notice of Effectiveness
  5. ARS Other Annual Report to Security Holders
  6. DEFA14A Proxy Proxy Materials
  7. 144 Insider Sale of Securities
  8. S-8 Other Securities Offered to Employees in Benefit Plans
  9. 144 Insider Sale of Securities
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. EFFECT Other Notice of Effectiveness
  14. DEFA14A Proxy Proxy Materials
  15. S-8 Other Securities Offered to Employees in Benefit Plans
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. DEFA14A Proxy Proxy Materials
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. DEFA14A Proxy Proxy Materials
  20. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit

Page 2 of 3 · 49 filings